The CE Mark will should get approval after
The (Stage-1 - 20 patient safety assessment)
(28 patients) have been recruited so far
With (14 successfully implanted) showing no serious adverse effects
So the (Stage-1) safety assessment should be completed easily by the end of the year,
And therefore, we should see CE approval in the (1st Quarter, 2018) IMHO
OSL Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)